Clinical Factors Associated with Weight Gain in French-Canadian Children and Adolescents Treated With Second Generation Antipsychotics: A 24-Month Retrospective Study
نویسندگان
چکیده
Second generation antipsychotics (SGAs), which are medications used to treat a variety of psychiatric disorders, are associated with weight gain, obesity, and increased cardiovascular risk in children, adolescents as well as in adult populations [1-3]. A source of concern is increasing evidence suggesting a greater or exigenic effect of SGAs in youth compared to adults [3-8], especially considering childhood obesity adversely affects nearly every organ system, causing substantial morbidity and mortality in adulthood [9].
منابع مشابه
Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
OBJECTIVE To review the metabolic consequences of second-generation antipsychotics in youth and current monitoring and intervention guidelines for optimal treatment. BACKGROUND Second-generation antipsychotics have largely replaced the use of first-generation antipsychotics in treating psychotic disorders in youth. In addition, there has been a dramatic increase in using these medications to ...
متن کاملMetabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.
Second-generation antipsychotics (SGA) are being used more often than ever before in children and adolescents with psychotic and a wide range of non-psychotic disorders. Several SGA have received regulatory approval for some paediatric indications in various countries, but off-label use is still frequent. The aim of this paper was to perform a systematic review and critically evaluate the liter...
متن کاملConcurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid.
OBJECTIVE This study examined the prevalence of and factors associated with concurrent use of long-acting stimulants (LAS) and second-generation antipsychotic agents among children and adolescents with attention-deficit hyperactivity disorder (ADHD). METHODS The study involved retrospective longitudinal analysis of 2003-2007 Medicaid data from four states for children and adolescents between ...
متن کاملMetabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
OBJECTIVE To identify factors associated with incident cardiovascular events and metabolic disturbance in children and adolescents treated with antipsychotics. DESIGN A retrospective cohort design evaluating Medicaid medical and pharmacy claims. SETTING South Carolina's Medicaid program covering outpatient and inpatient medical services and medication prescriptions from January 1, 1996, thr...
متن کاملPreliminary and ongoing French multicenter prospective naturalistic study of adverse events of antipsychotic treatment in naive children and adolescents
BACKGROUND The prescription of antipsychotics (AP), and especially second generation AP, is increasing worldwide in the pediatric population. Most prescriptions are off-label and despite the identification of frequent and potentially severe adverse events (AE), there are only a few guidelines for the safety management. France is one of the countries with no official safety guidelines. METHODS...
متن کامل